Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes

M.C.M. Bunck, A. Corner, B. Eliasson, R.J. Heine, R.M. Shaginian, M.R. Taskinen, U. Smith, H. Yki-Jarvinen, M. Diamant

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)848
Publication statusPublished - 2010

Cite this